Status: Not yet recruiting
A Study of AK112 in Combination With VG2025 in Colorectal Cancer With Liver Metastases
An open-label, multicenter, phase Ib/II study of AK112 in combination with VG2025 for advanced colorectal cancer with liver metastases.
Participants needed: 72
Trial details
Phase: Phase 1, Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: AkesoUpdated: Jan 21, 2026Locations: 1
Eligibility criteria
Signed informed consent [+8]
Histologically or cytologically confirmed non-adenocarcinoma or mixed-type tumor... [+17]